 Hemispherx then began to move clinical trials to Canada and Belgium.In Belgium, rintatolimod has been available for use since the drug's trial beginning in May 1996.It has also been available under Canada's Emergency Drug Release Program for both chronic fatigue syndrome (CFS) and HIV treatment since 1996, with marketing rights controlled by Biovail Corporation International.